Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Cancer Therapies02:49

Cancer Therapies

10.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients.

Oncology letters·2022
Same author

Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy <i>in vitro</i> and <i>in vivo</i>.

Oncology reports·2022
Same author

Naltrexone at low doses (LDN) and its relevance to cancer therapy.

Expert review of anticancer therapy·2022
Same author

The immuno-oncological implications of insulin.

Life sciences·2020
Same author

Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.

Oncology reports·2020
Same author

The efficacy of chemotherapeutic drug combinations may be predicted by concordance of gene response to the single agents.

Oncology letters·2020
Same journal

Utility of serum Krebs von den Lungen-6 and surfactant protein D levels for differential diagnosis of immune checkpoint inhibitor-related pneumonitis.

Immunotherapy·2026
Same journal

Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysis.

Immunotherapy·2026
Same journal

Anti-TIGIT therapies in digestive cancers: from immune evasion to precision immunotherapy.

Immunotherapy·2026
Same journal

CAR cellular therapies for acute myeloid leukemia: current landscape and future directions.

Immunotherapy·2026
Same journal

Recent advances in bispecific natural killer cell engagers for cancer immunotherapy.

Immunotherapy·2026
Same journal

Exploring global research trends in sublingual immunotherapy of allergic rhinitis: a comprehensive bibliometric analysis.

Immunotherapy·2026
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

13.0K

Rationale for combining immunotherapy with chemotherapy.

Angus G Dalgleish

    Immunotherapy
    |March 26, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Combining cancer immunotherapy with traditional treatments like chemotherapy and radiotherapy may improve outcomes. Low-dose chemotherapy can also enhance immune responses by targeting suppressor cells, challenging previous assumptions about treatment compatibility.

    Keywords:
    checkpoint inhibitorschemotherapycytokinesimmunotherapypotential synergyregulatory and suppressor cell inhibitorsvaccines

    More Related Videos

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
    15:24

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

    Published on: December 16, 2022

    4.2K
    Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
    12:19

    Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

    Published on: June 7, 2024

    2.2K

    Related Experiment Videos

    Last Updated: Apr 15, 2026

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
    15:04

    Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

    Published on: January 19, 2019

    13.0K
    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
    15:24

    Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

    Published on: December 16, 2022

    4.2K
    Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
    12:19

    Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

    Published on: June 7, 2024

    2.2K

    Area of Science:

    • Oncology
    • Immunology
    • Cancer Therapeutics

    Background:

    • Immunotherapy is often viewed as a standalone cancer treatment.
    • Chemotherapy has been considered immunosuppressive, limiting combination strategies.
    • Tumors induce immune suppression, which can hinder treatment efficacy.

    Purpose of the Study:

    • To explore the integration of cell-death-inducing modalities with immunotherapy.
    • To re-evaluate the combination of chemotherapy and radiotherapy with immunotherapy.
    • To investigate strategies for reversing tumor-induced immune suppression.

    Main Methods:

    • Review of existing literature on combined cancer treatment modalities.
    • Analysis of the effects of radiotherapy and chemotherapy on immune responses.
    • Examination of low-dose chemotherapy's impact on regulatory and suppressor cells.

    Main Results:

    • Combining cell-death-inducing therapies (radiotherapy, chemotherapy) with immunotherapy is feasible.
    • Nonspecific immune stimulation can enhance responses to radiotherapy and chemotherapy.
    • Low-dose chemotherapy agents selectively inhibit immune suppressor cells.

    Conclusions:

    • Combining immunotherapy with chemotherapy and radiotherapy presents a promising therapeutic approach.
    • Modulating the tumor microenvironment's immune suppressive effects is crucial.
    • Low-dose chemotherapy offers a novel strategy to potentiate immunotherapy and other treatments.